Biofrontera annual operating expenses
2020
2021
2022
2023
2024
2025
Biofrontera Operating Expenses Growth & History (BFRI)
Biofrontera's operating expenses was $53.1M for fiscal 2025.
View full Biofrontera company overviewBiofrontera annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $53.1M | −$1.5M | −2.71% |
| 2024 | 2024-12-31 | $54.5M | −$2.2M | −3.91% |
| 2023 | 2023-12-31 | $56.7M | $9.5M | +20.09% |
| 2022 | 2022-12-31 | $47.3M | −$2.0M | −4.15% |
| 2021 | 2021-12-31 | $49.3M | $20.8M | +73.26% |
| 2020 | 2020-12-31 | $28.5M | — | — |
Biofrontera quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.5M | −$1.6M | −11.21% |
| Q1 2026 | 2026-03-31 | $14.4M | $1.3M | +9.66% |
| Q4 2025 | 2025-12-31 | $12.5M | −$1.7M | −12.10% |
| Q3 2025 | 2025-09-30 | $13.3M | −$706,000 | −5.05% |
| Q2 2025 | 2025-06-30 | $14.1M | $1.2M | +9.29% |
| Q1 2025 | 2025-03-31 | $13.1M | −$244,000 | −1.82% |
| Q4 2024 | 2024-12-31 | $14.3M | −$190,000 | −1.31% |
| Q3 2024 | 2024-09-30 | $14.0M | $456,000 | +3.37% |
| Q2 2024 | 2024-06-30 | $12.9M | −$1.6M | −11.25% |
| Q1 2024 | 2024-03-31 | $13.4M | −$846,000 | −5.95% |
| Q4 2023 | 2023-12-31 | $14.5M | −$1.3M | −8.27% |
| Q3 2023 | 2023-09-30 | $13.5M | $5.6M | +69.78% |
| Q2 2023 | 2023-06-30 | $14.5M | $3.9M | +36.35% |
| Q1 2023 | 2023-03-31 | $14.2M | $1.4M | +10.61% |
| Q4 2022 | 2022-12-31 | $15.8M | $4.7M | +42.69% |
| Q3 2022 | 2022-09-30 | $8.0M | −$12.5M | −61.05% |
| Q2 2022 | 2022-06-30 | $10.7M | $1.1M | +11.81% |
| Q1 2022 | 2022-03-31 | $12.9M | $4.6M | +55.48% |
| Q4 2021 | 2021-12-31 | $11.0M | — | — |
| Q3 2021 | 2021-09-30 | $20.4M | $15.3M | +296.87% |
| Q2 2021 | 2021-06-30 | $9.5M | — | — |
| Q1 2021 | 2021-03-31 | $8.3M | — | — |
| Q3 2020 | 2020-09-30 | $5.2M | — | — |
Biofrontera operating expenses trends
Over the last five fiscal years, Biofrontera's operating expenses increased from $28.5M to $53.1M, a change of $24.6M. The latest reported quarter, Q2 2026, shows $12.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera source filings ↗